STAGE IVA LUNG CANCER AJCC V8
Clinical trials for STAGE IVA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart radiation adjustments aim to protect Patients' hearts and lungs
Disease control Recruiting nowThis study is testing whether updating radiation treatment plans at set times during therapy can reduce damage to healthy heart and lung tissue in people with non-small cell lung cancer. Researchers want to see if this adaptive approach lowers side effects like lung inflammation …
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early trial aims to supercharge immune system against lung cancer
Disease control Recruiting nowThis early study is testing if adding a low-dose immune stimulant (IL-2) to a standard immunotherapy drug (pembrolizumab) can better fight advanced non-small cell lung cancer. The main goal is to see how this combination changes the patient's immune cells. Researchers will also c…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug duo aims to block growth of advanced lung cancer
Disease control Recruiting nowThis early-stage study is testing a new combination of two drugs, osimertinib and tegavivint, for people with a specific type of advanced lung cancer that has spread. The main goal is to find the safest and most effective dose of the drug pair. Researchers will also check if the …
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Targeted pill trial aims to control advanced cancers by blocking key growth signals
Disease control Recruiting nowThis study is testing an oral medication called avapritinib for people with advanced solid tumors that have spread and have specific genetic changes (mutations in the CKIT or PDGFRA genes). The drug aims to block the signals that help these tumor cells grow, potentially controlli…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hope for tough lung cancers: early trial tests Dual-Attack therapy
Disease control Recruiting nowThis early-stage trial is testing a new combination of two immunotherapy drugs, PBF-1129 and nivolumab, for people with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand the side effects. Researchers also want…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New combo therapy tested to fight tough lung Cancer's return
Disease control Recruiting nowThis study is testing if a combination of two drugs can help control advanced small cell lung cancer that has returned or spread after initial treatment. It will involve about 56 adults whose cancer has progressed after standard chemo-immunotherapy. The goal is to see if adding a…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Glowing dye could help surgeons spot hidden lung cancer
Diagnosis Recruiting nowThis study is testing a new imaging dye that attaches to lung cancer cells and glows under a special camera. The goal is to help surgeons see the cancer more clearly during an operation, which could help them remove all of the cancer while leaving more healthy tissue. The trial w…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
Yoga study aims to ease cancer treatment burden for patients and families
Symptom relief Recruiting nowThis study is testing whether a yoga program for patients and their caregivers can improve physical function and quality of life during radiation treatment for lung or esophageal cancer. It will compare yoga sessions to educational sessions to see which helps patients walk farthe…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Could poop transplants ease cancer drug side effects?
Knowledge-focused Recruiting nowThis study aims to understand why some cancer patients develop severe diarrhea and colon inflammation (colitis) while taking powerful immunotherapy drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 patients with melanoma…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 05, 2026 14:00 UTC